BRAND_ANALYSIS#ROCHEHEALTH & PHARMA#18 OF 26 IN HEALTH & PHARMAALIGNED
Roche
· Private · Updated 09 Jul 2026 08:27 UTC
#612 of 1208 overall by tension · #18 of 26 in Health & Pharma
13Aligned
The Balanced
Analysis
Pharma giant: C=57/B=70 with 0.70 sentiment suggests healthcare companies have recovered reputation lost in the pandemic. Roche's drug portfolio speaks louder than any corporate narrative ever could.
IN THE NEWS (100 articles this week)
Inflammatory bowel diseases - Roche
Roche orchestrates phase 3 lung cancer win over Amgen and BMS - Fierce Biotech
Roche KRAS drug succeeds in head-to-head lung cancer study - BioPharma Dive